Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
November 20 2024 - 4:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of: November 2024
Commission file number: 001-41557
CLEARMIND
MEDICINE INC.
(Translation of registrant’s name into English)
101 – 1220 West 6th Avenue
Vancouver, British Columbia
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
CONTENTS
On
November 20, 2024, Clearmind Medicine Inc. (the “Company”) published a notice (the “Notice”) that it will
hold an Annual and Special Meeting of Shareholders on January 6, 2025, with a record date (the “Record Date”) on November
28, 2024. After the Record Date, the Company will distribute the proxy materials (which will include the full version of the proposed
resolutions) and a proxy card to all shareholders of record as of the Record Date. The Notice is furnished as Exhibit 99.1 herewith.
This 6-K incorporated by reference
into the Registrant’s Registration Statements on Form F-3 (File No. 333-275991, 333-270859, 333-273293),
filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the extent
not superseded by documents or reports subsequently filed or furnished.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
Clearmind Medicine, Inc. |
|
(Registrant) |
|
|
|
Date: November 20, 2024 |
By: |
/s/ Adi Zuloff-Shani |
|
Name: |
Adi Zuloff-Shani |
|
Title: |
Chief Executive Officer |
Exhibit 99.1
|
|
|
November 20, 2024 |
|
510 Burrard St, 3rd Floor |
|
|
Vancouver BC, V6C 3B9 |
|
|
www.computershare.com |
To: | All Canadian Securities Regulatory Authorities |
| NASDAQ Exchange |
Subject: CLEARMIND MEDICINE INC.
Dear Sir/Madam:
We advise of the following with respect to the upcoming Meeting of Security Holders for the subject
Issuer:
Meeting Type : |
Annual and Special Meeting |
Record Date for Notice of Meeting : |
November 28, 2024 |
Record Date for Voting (if applicable) : |
November 28, 2024 |
Beneficial Ownership Determination Date : |
November 28, 2024 |
Meeting Date : |
January 06, 2025 |
Meeting Location (if available) : |
Virtual Meeting |
Issuer sending proxy related materials directly to NOBO: |
Yes |
Issuer paying for delivery to OBO: |
No |
|
|
Notice and Access (NAA) Requirements: |
|
NAA for Beneficial Holders |
No |
NAA for Registered Holders |
No |
Voting Security Details: |
|
|
|
|
|
|
|
|
|
Description |
|
CUSIP Number |
|
ISIN |
COMMON CLASS |
|
185053402 |
|
CA1850534027 |
Sincerely,
Computershare
Agent for CLEARMIND MEDICINE INC.
Clearmind Medicine (NASDAQ:CMND)
Historical Stock Chart
From Nov 2024 to Dec 2024
Clearmind Medicine (NASDAQ:CMND)
Historical Stock Chart
From Dec 2023 to Dec 2024